InvestorsHub Logo
Followers 1
Posts 25
Boards Moderated 0
Alias Born 03/26/2012

Re: gestalt2 post# 10620

Tuesday, 02/14/2017 3:40:09 PM

Tuesday, February 14, 2017 3:40:09 PM

Post# of 232149
That does make sense! But for the sake of argument; if CytoDyn was to manufacture market and ultimately sell to the end user each billion in revenues (at a 75% net revenue profit) at a 10 times PE would be $30 per share. Since the growth potential would be higher than 1 billion the PE would be much higher!! I need to reiterate , that 44% of the HIV infected patients that are not on any treatment, I feel that PRO 140 could fill this void and represent at least a $10B market potential. Gilead would love to swoop in and take that market but they can't with there toxic HAART therapies! PRO 140 can!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News